Amgen, Inc. (AMGN)
432.31
-4.68
(-1.07%)
USD |
NASDAQ |
Aug 28, 15:56
Amgen Cash from Operations (Quarterly) : 4.002B for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.002B |
| March 31, 2026 | 2.189B |
| December 31, 2025 | 1.603B |
| September 30, 2025 | 4.684B |
| June 30, 2025 | 2.28B |
| March 31, 2025 | 1.391B |
| December 31, 2024 | 4.771B |
| September 30, 2024 | 3.571B |
| June 30, 2024 | 2.459B |
| March 31, 2024 | 689.00M |
| December 31, 2023 | 538.00M |
| September 30, 2023 | 2.76B |
| June 30, 2023 | 4.109B |
| March 31, 2023 | 1.064B |
| December 31, 2022 | 2.649B |
| September 30, 2022 | 2.978B |
| June 30, 2022 | 1.93B |
| March 31, 2022 | 2.164B |
| December 31, 2021 | 2.808B |
| September 30, 2021 | 2.418B |
| June 30, 2021 | 1.931B |
| March 31, 2021 | 2.104B |
| December 31, 2020 | 2.153B |
| September 30, 2020 | 3.368B |
| June 30, 2020 | 2.842B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.134B |
| December 31, 2019 | 2.514B |
| September 30, 2019 | 3.377B |
| June 30, 2019 | 1.414B |
| March 31, 2019 | 1.845B |
| December 31, 2018 | 3.194B |
| September 30, 2018 | 3.273B |
| June 30, 2018 | 2.102B |
| March 31, 2018 | 2.727B |
| December 31, 2017 | 3.012B |
| September 30, 2017 | 3.454B |
| June 30, 2017 | 2.326B |
| March 31, 2017 | 2.385B |
| December 31, 2016 | 3.10B |
| September 30, 2016 | 2.662B |
| June 30, 2016 | 2.677B |
| March 31, 2016 | 1.915B |
| December 31, 2015 | 2.06B |
| September 30, 2015 | 2.874B |
| June 30, 2015 | 2.814B |
| March 31, 2015 | 1.329B |
| December 31, 2014 | 2.445B |
| September 30, 2014 | 2.741B |
| June 30, 2014 | 2.227B |
| March 31, 2014 | 1.142B |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 3.573B |
| Regeneron Pharmaceuticals, Inc. | 813.00M |
| AbbVie, Inc. | 3.436B |
| Biogen, Inc. | 448.90M |
| Vertex Pharmaceuticals, Inc. | 1.125B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -569.00M |
| Cash from Financing (Quarterly) | -1.482B |
| Free Cash Flow | 10.18B |
| Free Cash Flow Per Share (Quarterly) | 6.414 |
| Free Cash Flow to Equity (Quarterly) | 3.508B |
| Free Cash Flow to Firm (Quarterly) | 4.077B |
| Free Cash Flow Yield | 4.33% |